Exact Mass: 379.1652

Exact Mass Matches: 379.1652

Found 87 metabolites which its exact mass value is equals to given mass value 379.1652, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Kasugamycin

2-amino-2-[(2R,3S,5S,6R)-5-amino-2-methyl-6-[(2S,3S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyoxan-3-yl]iminoacetic acid

C14H25N3O9 (379.1591)


An amino cyclitol glycoside that is isolated from Streptomyces kasugaensis and exhibits antibiotic and fungicidal properties. Kasugamycin is an amino cyclitol glycoside that is isolated from Streptomyces kasugaensis and exhibits antibiotic and fungicidal properties. It has a role as a bacterial metabolite, a protein synthesis inhibitor and an antifungal agrochemical. It is an amino cyclitol glycoside, an aminoglycoside antibiotic, a monosaccharide derivative, a carboxamidine and an antibiotic fungicide. Kasugamycin has been reported in Streptomyces celluloflavus and Streptomyces kasugaensis. Kasugamycin. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=6980-18-3 (retrieved 2024-12-11) (CAS RN: 6980-18-3). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

   

droperidol

droperidol

C22H22FN3O2 (379.1696)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AD - Butyrophenone derivatives D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C323 - Butyrophenone D005765 - Gastrointestinal Agents > D000932 - Antiemetics CONFIDENCE standard compound; INTERNAL_ID 1207 INTERNAL_ID 1207; CONFIDENCE standard compound CONFIDENCE standard compound; EAWAG_UCHEM_ID 3679 Droperidol is a butyrophenone-type Dopamine-2 receptor antagonist.

   

Droperidol

1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl}-2,3-dihydro-1H-benzo[D]imidazol-2-one

C22H22FN3O2 (379.1696)


A butyrophenone with general properties similar to those of haloperidol. It is used in conjunction with an opioid analgesic such as fentanyl to maintain the patient in a calm state of neuroleptanalgesia with indifference to surroundings but still able to cooperate with the surgeon. It is also used as a premedicant, as an antiemetic, and for the control of agitation in acute psychoses. (From Martindale, The Extra Pharmacopoeia, 29th ed, p593) D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AD - Butyrophenone derivatives D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C323 - Butyrophenone D005765 - Gastrointestinal Agents > D000932 - Antiemetics Droperidol is a butyrophenone-type Dopamine-2 receptor antagonist.

   

2-(Arabinosylamino)-3-(glucosylamino)propanenitrile

3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino}-2-[(3,4,5-trihydroxyoxan-2-yl)amino]propanenitrile

C14H25N3O9 (379.1591)


2-(Arabinosylamino)-3-(glucosylamino)propanenitrile is found in pulses. 2-(Arabinosylamino)-3-(glucosylamino)propanenitrile is a constituent of the seeds of Lathyrus sativus (chickling pea). Constituent of the seeds of Lathyrus sativus (chickling pea). 2-(Arabinosylamino)-3-(glucosylamino)propanenitrile is found in pulses.

   

Merafloxacin

1-ethyl-7-{3-[(ethylamino)methyl]pyrrolidin-1-yl}-6,8-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

C19H23F2N3O3 (379.1707)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic

   

2-(4-(2-Methylpyridin-4-yl)phenyl)-N-(4-(pyridin-3-yl)phenyl)acetamide

2-(4-(2-Methylpyridin-4-yl)phenyl)-N-(4-(pyridin-3-yl)phenyl)acetamide

C25H21N3O (379.1685)


   
   

oryzamutaic acid H

oryzamutaic acid H

C18H25N3O6 (379.1743)


   

12-hydroxy-4-methyl-8,11,15-trioxo-19H-(13betaH)-4,8-seco-crotalanane-14beta-carboxylic acid lactone|14-carboxy-8,12-dihydroxy-4alpha-methyl-11,15-dioxo-(13betaH,14betaH)-14,19-dihydro-crotalananium betaine 12-lactone|Retusamin|retusamine

12-hydroxy-4-methyl-8,11,15-trioxo-19H-(13betaH)-4,8-seco-crotalanane-14beta-carboxylic acid lactone|14-carboxy-8,12-dihydroxy-4alpha-methyl-11,15-dioxo-(13betaH,14betaH)-14,19-dihydro-crotalananium betaine 12-lactone|Retusamin|retusamine

C19H25NO7 (379.1631)


   

bruceolline M

bruceolline M

C19H25NO7 (379.1631)


An indole alkaloid that is 1H-indole substituted by a 3-hydroxy-3-methyl-2-oxobutyl group at position 3 and a beta-D-glucopyranosyl group attached to the indolic nitrogen. It has been isolated from the ethanol extract of the stems of Brucea mollis.

   

dehydrosinefungin

dehydrosinefungin

C15H21N7O5 (379.1604)


   
   
   
   

SCHEMBL17305518

SCHEMBL17305518

C18H25N3O6 (379.1743)


   
   
   
   
   
   
   
   
   
   
   
   

(E)-1-(L-cysteinylglycin-S-yl)-N-hydroxy-omega-(methylsulfanyl)nonan-1-imine

(E)-1-(L-cysteinylglycin-S-yl)-N-hydroxy-omega-(methylsulfanyl)nonan-1-imine

C15H29N3O4S2 (379.1599)


   

Kasugamycin_major

Kasugamycin_major

C14H25N3O9 (379.1591)


   
   
   
   
   
   
   
   

2-(Arabinosylamino)-3-(glucosylamino)propanenitrile

3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino}-2-[(3,4,5-trihydroxyoxan-2-yl)amino]propanenitrile

C14H25N3O9 (379.1591)


   

6-CHLORO-2-HEXANONE

6-CHLORO-2-HEXANONE

C18H25N3O6 (379.1743)


   

Z-Ile-Gly-Gly-OH

Z-Ile-Gly-Gly-OH

C18H25N3O6 (379.1743)


   

TERT-BUTYL 5-((4-METHYLPIPERAZIN-1-YL)SULFONYL)-1H-INDOLE-1-CARBOXYLATE

TERT-BUTYL 5-((4-METHYLPIPERAZIN-1-YL)SULFONYL)-1H-INDOLE-1-CARBOXYLATE

C18H25N3O4S (379.1566)


   

z-gly-gly-leu-oh

z-gly-gly-leu-oh

C18H25N3O6 (379.1743)


   
   

Frovatriptan

Frovatriptan Succinate monohydrate

C18H25N3O6 (379.1743)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist Frovatriptan succinate hydrate ((R)-Frovatriptan succinate hydrate) is a potent, high affinity, selective and orally active 5-HT1B (pK50 of 8.2) and 5-HT1D receptor agonist. Frovatriptan succinate hydrate exhibits >10-fold selectivity for 5-HT1B and 5-HT1D over 5-HT1A, 5-HT1F, and 5-HT7 and >1000-fold selectivity over other 5-HT, dopamine, histamine H1, and α1-adrenoceptor. Frovatriptan succinate hydrate has the potential for migraine research[1][2].

   
   

1-(2,3-EPOXYPROPYL)-4-PHENYLPIPERAZINE

1-(2,3-EPOXYPROPYL)-4-PHENYLPIPERAZINE

C18H25N3O4S (379.1566)


   

Wnt-C59(C59)

2-(4-(2-Methylpyridin-4-yl)phenyl)-N-(4-(pyridin-3-yl)phenyl)acetamide

C25H21N3O (379.1685)


   

dicyclohexylamine (S)-2-hydroxy-4-(methylselanyl)butanoate

dicyclohexylamine (S)-2-hydroxy-4-(methylselanyl)butanoate

C17H33NO3Se (379.1626)


   

Benzyl-2-N-BOC-5-carbomethoxy-4-oxo-pentanate

Benzyl-2-N-BOC-5-carbomethoxy-4-oxo-pentanate

C19H25NO7 (379.1631)


   
   

(6E)-2,5-diamino-6-[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-ylidene]hexanoic acid

(6E)-2,5-diamino-6-[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-ylidene]hexanoic acid

C15H21N7O5 (379.1604)


   

methyl 4-{3-[1-(3-nitro-2-pyridinyl)-4-piperidinyl]-1H-pyrazol-5-yl}phenyl ether

methyl 4-{3-[1-(3-nitro-2-pyridinyl)-4-piperidinyl]-1H-pyrazol-5-yl}phenyl ether

C20H21N5O3 (379.1644)


   

5-Tert-butyl-3-(4-chlorophenyl)-7-(2-ethyl-1-imidazolyl)pyrazolo[1,5-a]pyrimidine

5-Tert-butyl-3-(4-chlorophenyl)-7-(2-ethyl-1-imidazolyl)pyrazolo[1,5-a]pyrimidine

C21H22ClN5 (379.1564)


   

2-[[(2R)-2-amino-3-[(E)-N-hydroxy-C-(8-methylsulfanyloctyl)carbonimidoyl]sulfanylpropanoyl]amino]acetic acid

2-[[(2R)-2-amino-3-[(E)-N-hydroxy-C-(8-methylsulfanyloctyl)carbonimidoyl]sulfanylpropanoyl]amino]acetic acid

C15H29N3O4S2 (379.1599)


   

Phe-Val-Asp

Phe-Val-Asp

C18H25N3O6 (379.1743)


A tripeptide composed of L-phenylalanine, L-valine, and L-aspartic acid joined by peptide linkages.

   

L-threonyl-L-prolyl-L-tyrosine

L-threonyl-L-prolyl-L-tyrosine

C18H25N3O6 (379.1743)


   
   
   
   
   
   

(2S,3R,4S)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

(2S,3R,4S)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

C22H25N3OS (379.1718)


   

(2R,3S,4S)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

(2R,3S,4S)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

C22H25N3OS (379.1718)


   

(2R,3R,4S)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

(2R,3R,4S)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

C22H25N3OS (379.1718)


   

(2R,3R,4R)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

(2R,3R,4R)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

C22H25N3OS (379.1718)


   

(2S,3S,4S)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

(2S,3S,4S)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

C22H25N3OS (379.1718)


   

(2S,3R,4R)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

(2S,3R,4R)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

C22H25N3OS (379.1718)


   

(2R,3S,4R)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

(2R,3S,4R)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

C22H25N3OS (379.1718)


   
   
   
   
   
   
   
   
   
   
   
   

Thr-Pro-Tyr

Thr-Pro-Tyr

C18H25N3O6 (379.1743)


A tripeptide composed of L-threonine, L-proline, and L-tyrosine joined by peptide linkages.

   

N(6)-dansyl-L-lysine

N(6)-dansyl-L-lysine

C18H25N3O4S (379.1566)


An L-lysine derivative with a dansyl group at the N(6)-position.

   

(1r,4r,7s,11z,18s)-4-ethyl-7,14,18-trimethyl-2,6,9-trioxa-14-azatricyclo[9.5.1.1⁴,⁷]octadec-11-ene-3,5,8,17-tetrone

(1r,4r,7s,11z,18s)-4-ethyl-7,14,18-trimethyl-2,6,9-trioxa-14-azatricyclo[9.5.1.1⁴,⁷]octadec-11-ene-3,5,8,17-tetrone

C19H25NO7 (379.1631)


   

3-({1-[(5-aminopentyl)-c-hydroxycarbonimidoyl]-2-(4-hydroxyphenyl)ethyl}-c-hydroxycarbonimidoyl)oxirane-2-carboxylic acid

3-({1-[(5-aminopentyl)-c-hydroxycarbonimidoyl]-2-(4-hydroxyphenyl)ethyl}-c-hydroxycarbonimidoyl)oxirane-2-carboxylic acid

C18H25N3O6 (379.1743)


   

(2s,3s)-3-{[(1s)-1-[(5-aminopentyl)-c-hydroxycarbonimidoyl]-2-(4-hydroxyphenyl)ethyl]-c-hydroxycarbonimidoyl}oxirane-2-carboxylic acid

(2s,3s)-3-{[(1s)-1-[(5-aminopentyl)-c-hydroxycarbonimidoyl]-2-(4-hydroxyphenyl)ethyl]-c-hydroxycarbonimidoyl}oxirane-2-carboxylic acid

C18H25N3O6 (379.1743)


   

(n'-{5-amino-2-methyl-6-[(2,3,4,5,6-pentahydroxycyclohexyl)oxy]oxan-3-yl}carbamimidoyl)formic acid

(n'-{5-amino-2-methyl-6-[(2,3,4,5,6-pentahydroxycyclohexyl)oxy]oxan-3-yl}carbamimidoyl)formic acid

C14H25N3O9 (379.1591)


   

5-(3-amino-3-carboxypropyl)-1h,2h,3h,8h,9h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-3,8-dicarboxylic acid

5-(3-amino-3-carboxypropyl)-1h,2h,3h,8h,9h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-3,8-dicarboxylic acid

C18H25N3O6 (379.1743)


   

4-ethyl-7,14,18-trimethyl-2,6,9-trioxa-14-azatricyclo[9.5.1.1⁴,⁷]octadec-11-ene-3,5,8,17-tetrone

4-ethyl-7,14,18-trimethyl-2,6,9-trioxa-14-azatricyclo[9.5.1.1⁴,⁷]octadec-11-ene-3,5,8,17-tetrone

C19H25NO7 (379.1631)


   

{n'-[(2r,3s,5s,6r)-5-amino-2-methyl-6-{[(2r,3s,5s,6s)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}oxan-3-yl]carbamimidoyl}formic acid

{n'-[(2r,3s,5s,6r)-5-amino-2-methyl-6-{[(2r,3s,5s,6s)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}oxan-3-yl]carbamimidoyl}formic acid

C14H25N3O9 (379.1591)


   

(3s,8s,11as,11bs)-5-[(3s)-3-amino-3-carboxypropyl]-1h,2h,3h,8h,9h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-3,8-dicarboxylic acid

(3s,8s,11as,11bs)-5-[(3s)-3-amino-3-carboxypropyl]-1h,2h,3h,8h,9h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-3,8-dicarboxylic acid

C18H25N3O6 (379.1743)